TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2026
Back to search
Official data from USPTO
ZUNHAYRE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZUNHAYRE
ST13
US500000098450533Class
5, 42, 44
Filing
98450533
Registration
7798467
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/30/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/14/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
LONDON, GB
Examiner
DONEGAN, DANIEL P
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
VERONA PHARMA LIMITED
Verona Pharma PLC
Representatives
Palak Mayani Merck & Co., Inc.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma
Class 42
Scientific research for medical purposesthe research and development of pharmaceutical preparations for the treatment of respiratory conditions and diseasein particularchronic obstructive pulmonary diseasecystic fibrosis and asthma
Class 44
Medical treatment services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma
Publications
History of USPTO decisions and trademark events.
31 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/29/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/29/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/29/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/20/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2025
ALIE
ASSIGNED TO LIE
01/24/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/14/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/21/2024
GNSL
LETTER OF SUSPENSION E-MAILED
08/21/2024
CNSL
SUSPENSION LETTER WRITTEN
08/21/2024
DOCK
ASSIGNED TO EXAMINER
08/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2024
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
03/19/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/19/2024
NWAP
NEW APPLICATION ENTERED
03/14/2024
Continuous trademark protection
Get notified about every new filing that threatens ZUNHAYRE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.